Alkem Laboratories Limited (BOM:539523)
India · Delayed Price · Currency is INR 5,374.75
-3.25 (-0.06%)
At close: Jun 19, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 641.71 billion as of June 22, 2026. Its market cap has increased by 5.27% in one year.
Market Cap
641.71B
Enterprise Value
617.54B
Revenue
147.12B
Ranking
n/a
PE Ratio
27.88
Stock Price
5,374.75
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 641.71B, an increase of 288.43%. That is a compound annual growth rate of 13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 642.48B | -2.42% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.50T |
| Lupin | 1.08T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |